Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF)

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 2, 2015, Pages 325-330

  Bakir M ^a   Gozel M G ^a   Koksal I ^b   Asik Z ^c   Gunal O ^d   Yilmaz H ^e   But, A ^f   Yilmaz G ^b   Engin, A ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^c Tokat State Hospital   (Turkey)

^d GAZIOSMANPASA UNIVERSITY   (Turkey)

^e ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^f ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CRIMEAN CONGO HEMORRHAGIC FEVER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTERMEDIATE RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEVERITY GRADING SCORE; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALIZATION; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84921776265     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2238-0     Document Type: Article

References (18)

1. Ergönül O (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:203–214
2. The Turkish Medical Association Publications (Türk Tabipleri Birligi Yayinlari) (2011) Scientific assessment report of the Crimean-Congo haemorrhagic fever. Available online at: http://www.ttb.org.tr/kutuphane/kirim_kongo_rpr.pdf. Accessed 17 July 2014
3. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B (2006) Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 12:551–554
4. Koksal I, Yilmaz G, Aksoy F, Aydin H, Yavuz I, Iskender S, Akcay K, Erensoy S, Caylan R, Aydin K (2010) The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol 47:65–68
5. Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB, Bavari S (2011) Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res 90:85–92
6. Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z (2012) A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis 49:105–110
7. Whitehouse CA (2004) Crimean-Congo hemorrhagic fever. Antiviral Res 64:145–160
8. Cevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A, Akinci E (2008) Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 12:374–379
9. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S (1989) The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11:S794–S800
10. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F (2010) The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol 47:361–365
11. Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N (2009) Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct 39:158–160
12. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H; Turkish CCHF Study Group (2005) Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 54:385–389
13. Onguru P, Dagdas S, Bodur H, Yilmaz M, Akinci E, Eren S, Özet G (2010) Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Clin Lab Anal 24:163–166
14. Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EK, Sari T, Kinikli S, Oral B, Demiroz AP (2010) Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis 42:516–521
15. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, Tasyaran MA (2006) Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 52:207–215
16. Dokuzoguz B, Celikbas AK, Gök ŞE, Baykam N, Eroglu MN, Ergönül Ö (2013) Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis 57:1270–1274
17. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, Ongürü P, Kubar A (2007) Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 45(7):e96–e100
18. Wölfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, Hewson R, Georges-Courbot MC, Papa A, Günther S, Drosten C (2007) Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis 13(7):1097–100